Pharmafile Logo
Pharmafocus logo
Advanced Search

MSI appoints senior consultant

January 17, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Watson, MSI Consultancy

Strategic pharma marketing consultancy firm The MSI Consultancy has appointed David Watson as a senior consultant, specialising in channel strategy. …

Appointment

Private equity firm pays $212m for Cambridge Major Labs

January 16, 2013
Manufacturing and Production American Capital, CML, Cambridge

Private equity firm American Capital has said it will pay $212 million to buy out Cambridge Major Laboratories (CML), a …

News
NICE image

The price of innovation

January 16, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, NICE, Rose, VBP

One of the strange paradoxes of our industry is that we have a very large number of new medicines in …

Feature
Astrazeneca image

AstraZeneca shakes up management

January 16, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Mackay, R&D, Soriot

AstraZeneca has taken its most dramatic steps yet to arrest decline, with chief executive Pascal Soriot axeing two senior positions …

News
andrea_rappagliosi_

Sanofi Pasteur MSD appoint president of Vaccines Europe

January 16, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrea Rappagliosi, Sanofi pasteur msd, vaccines

Vice president of Market Access, Health Policy & Medical Affairs at Sanofi Pasteur MSD Andrea Rappagliosi has been appointed president …

Appointment

Boehringer in oncology tie-up

January 16, 2013
Research and Development, Sales and Marketing Boehringer, Cancer, horizon, x-man

Boehringer Ingelheim has entered a five-year tie-up with a UK biotech company which specialises in helping research into personalised medicines. …

News
Tamoxifen image

NICE consults on tamoxifen

January 15, 2013
Sales and Marketing Cancer, Evista, NICE, lilly, tamoxifen

Patient groups have welcomed NICE’s new draft guideline recommending the use of preventive treatments in women who have a family …

News

Mitsubishi deal to buy Qualicaps will close in March

January 15, 2013
Manufacturing and Production Mitsubishi, Patheon, Qualicaps

Mitsubishi Chemical has agreed to buy Qualicaps from US private equity company Carlyle Group in the latest round of M&A …

News
Zytiga image

Zytiga extended in EU

January 15, 2013
Sales and Marketing EU, J&J, JJ, Janssen, Zytiga

Janssen is celebrating the European Commission’s decision to extend the licence for its prostate cancer treatment Zytiga. The once-daily pill …

News

Pharma manufacturing news in brief

January 14, 2013
Manufacturing and Production ADMA, Biotest, Catalent, Emerson, Nanocarrier, Orient Europharma, UCB

Facility news from Orient Europharma/NanoCarrier, Catalent and China Biologic, plus new contracts for Emerson Process Management and Biotest Pharma.

News
FDA Hamburg image

FDA publishes guidance on abuse-resistant opioids

January 14, 2013
Manufacturing and Production CDC, FDA, hamburg, opioids

The US Food and Drug Administration has issued draft guidance designed to combat the escalating problem of abuse of prescription …

News
lonza image

Lonza earmarks $15m for ADC plant expansion

January 14, 2013
Manufacturing and Production ADC, API, Lonza, Novasep

Swiss contract manufacturer Lonza has said it will invest around 14 million francs ($15m) in new capacity for antibody drug …

News
screen_shot_2013-01-14_at_13

Kathryn Gallant joins Insight Health US as joint chief executive

January 14, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gallant, insight health

The former managing partner for US health at Hall & Partners has joined the consultancy firm Insight Health US as …

Appointment
Eisai image

Eisai cancer drug fails

January 14, 2013
Research and Development, Sales and Marketing Cancer, Eisai, Morphotek, farletuzumab

Eisai’s investigational oncology treatment farletuzumab has failed to reach its primary endpoint in a late-stage trial. Farletuzumab (MORAb-003) did not …

News
merck_incweb

Merck withdraws Tredaptive

January 14, 2013
Sales and Marketing EMA, Merck, tredaptive

Merck is mounting a global operation to withdraw its cholesterol-lowering drug Tredaptive from the market following safety concerns. The company …

News
screen_shot_2013-01-11_at_10

Dominic Atkins joins Clinigen GAP in senior commercial role

January 14, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Clinigen, Dominic Atkins

Pharma services company Clinigen Global Access Programs (Clinigen GAP) has appointed Dominic Atkins as global business development director. In this …

Appointment
janssen image

Janssen’s diabetes drug Invokana recommended

January 11, 2013
Sales and Marketing Janssen, SGLT2, canagliflozin, diabetes, invokana

An FDA advisory committee has recommended Janssen’s new diabetes treatment canagliflozin for approval. To be marketed under the name Invokana, …

News
GSK image

EU submission for GSK and Theravance COPD drug

January 11, 2013
Sales and Marketing COPD, GSK, Theravance, UMEC/VI

GlaxoSmithKline and Theravance have submitted their chronic obstructive pulmonary disease (COPD) drug UMEC/VI to European regulators. The application follows the …

News
screen_shot_2013-01-11_at_09

Lundbeck appoints new global pricing and market access VP

January 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eggert, Jaszewski, Lundbeck

Barbara Jaszewski, has been appointed vice president of global pricing and market access at Lundbeck. She will be in charge …

Appointment

Public health budget ring-fenced

January 11, 2013
Sales and Marketing Hunt, NHS, government

Local authorities are to receive a total of £5.45 billion from the government over the next two years to spend …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026